Clinical Trials
Probuphine®
Probuphine is Titan’s novel, proprietary, potential long-term treatment for opioid addiction and chronic pain. Titan has completed a randomized, double-blind, placebo controlled, multi-center Phase III clinical study of Probuphine in the potential treatment of opioid addiction. This trial showed clinically meaningful and statistically significant results, which were announced in July 2008.